SCHWARTZ, PETER
 Distribuzione geografica
Continente #
NA - Nord America 20.990
AS - Asia 15.909
EU - Europa 12.347
SA - Sud America 2.020
AF - Africa 436
Continente sconosciuto - Info sul continente non disponibili 306
OC - Oceania 48
Totale 52.056
Nazione #
US - Stati Uniti d'America 20.529
CN - Cina 8.600
SG - Singapore 3.359
IE - Irlanda 2.608
UA - Ucraina 2.032
DE - Germania 1.820
HK - Hong Kong 1.551
BR - Brasile 1.492
FI - Finlandia 1.190
RU - Federazione Russa 1.114
VN - Vietnam 1.084
IT - Italia 939
SE - Svezia 903
FR - Francia 759
GB - Regno Unito 589
IN - India 269
CA - Canada 254
BD - Bangladesh 215
ZA - Sudafrica 177
AR - Argentina 174
IQ - Iraq 149
MX - Messico 108
JP - Giappone 97
EC - Ecuador 80
CO - Colombia 78
VE - Venezuela 74
NL - Olanda 73
PK - Pakistan 72
TR - Turchia 69
MA - Marocco 62
ID - Indonesia 57
ES - Italia 56
AT - Austria 51
BE - Belgio 47
PH - Filippine 47
PL - Polonia 42
CL - Cile 41
UZ - Uzbekistan 40
SA - Arabia Saudita 36
KE - Kenya 35
PY - Paraguay 33
TN - Tunisia 33
MU - Mauritius 32
MY - Malesia 32
AU - Australia 29
JO - Giordania 29
EG - Egitto 26
AE - Emirati Arabi Uniti 24
CR - Costa Rica 22
IR - Iran 22
AZ - Azerbaigian 21
NP - Nepal 19
PE - Perù 19
EU - Europa 17
IL - Israele 17
DZ - Algeria 16
NZ - Nuova Zelanda 16
BO - Bolivia 15
ET - Etiopia 15
JM - Giamaica 15
OM - Oman 13
UY - Uruguay 13
AL - Albania 12
KZ - Kazakistan 11
NI - Nicaragua 11
CZ - Repubblica Ceca 10
LT - Lituania 10
LV - Lettonia 10
PT - Portogallo 9
RO - Romania 9
SN - Senegal 9
TH - Thailandia 9
BG - Bulgaria 8
CH - Svizzera 8
KR - Corea 8
LB - Libano 8
PS - Palestinian Territory 8
RS - Serbia 8
DK - Danimarca 7
HU - Ungheria 7
PA - Panama 7
TT - Trinidad e Tobago 7
KG - Kirghizistan 6
SV - El Salvador 6
DO - Repubblica Dominicana 5
GE - Georgia 5
GR - Grecia 5
HN - Honduras 5
KW - Kuwait 5
PR - Porto Rico 5
QA - Qatar 5
BB - Barbados 4
AM - Armenia 3
BA - Bosnia-Erzegovina 3
BH - Bahrain 3
BW - Botswana 3
CG - Congo 3
CW - ???statistics.table.value.countryCode.CW??? 3
GT - Guatemala 3
HR - Croazia 3
Totale 51.701
Città #
Chandler 2.645
Dublin 2.603
Jacksonville 2.592
Nanjing 2.101
San Jose 1.953
Ashburn 1.649
Singapore 1.572
Dallas 1.521
Hong Kong 1.515
Beijing 984
Boardman 905
Nanchang 854
Council Bluffs 720
Princeton 641
Lawrence 603
Shenyang 600
Changsha 577
Hebei 571
Wilmington 560
Lauterbourg 540
Jiaxing 511
Munich 482
Helsinki 425
Los Angeles 410
Medford 408
Ho Chi Minh City 378
Tianjin 332
Hangzhou 326
Hanoi 263
Moscow 232
Redondo Beach 224
Buffalo 214
Ann Arbor 195
New York 182
Milan 169
Santa Clara 156
Woodbridge 148
Johannesburg 138
São Paulo 138
Shanghai 137
Verona 121
Norwalk 113
Tokyo 92
Orem 85
Toronto 82
Houston 74
Frankfurt am Main 71
Nuremberg 70
Seattle 65
Baghdad 64
Brooklyn 61
Fairfield 61
Kunming 59
Des Moines 58
Pavia 53
Zhengzhou 53
Guangzhou 52
Mcallen 52
Chicago 51
San Francisco 51
Chennai 50
Washington 50
Da Nang 44
Falkenstein 44
Jinan 44
Falls Church 42
Rome 41
Denver 39
Montreal 39
Haiphong 38
London 37
Montréal 37
Brussels 36
Ningbo 36
Tashkent 36
Warsaw 36
Atlanta 35
Mexico City 35
Belo Horizonte 34
Rio de Janeiro 34
Boston 33
Nairobi 33
Brasília 32
Phoenix 32
Stockholm 32
Turku 32
Columbus 30
The Dalles 30
Caracas 29
Curitiba 29
Guayaquil 29
Manchester 29
Amman 27
Dhaka 27
Amsterdam 25
Biên Hòa 24
Fuzhou 24
Lahore 24
City of London 23
Dearborn 23
Totale 33.916
Nome #
[A new experimental model for the study of arrhythmias dependent on the interaction between myocardial ischemia and sympathetic hyperactivity. I. Effects of phosphocreatinine]. 304
[Legal implications of medical guidelines. A Task Force of the European Society of Cardiology]. 270
[Changes of a reflex nature in the cardiac sympathetic activity induced with increases of arterial pressure in spinal animals]. 269
[Idiopathic syndrome of the long QT interval--the need for a prospective study]. 263
Vagus nerve stimulation: from pre-clinical to clinical application: challenges and future directions. 254
Identificazione di microRNA circolanti specificatamente sovra espressi in corso di infarto miocardico acuto. 252
Calcio antagonisti e aritmie da riperfusione miocardica 209
Common variants at SCN5A-SCN10A and HEY2 are associated with Brugada syndrome, a rare disease with high risk of sudden cardiac death. 188
Pathophysiological rationale for cardiac vagal denervation in the treatment of atrial fibrillation 170
Long QT and short QT syndromes. 164
[Activity of preganglionic sympathetic single fibers during experimental coronary occlusion]. 154
[Activity of afferent cardiac vagal fibers during experimental myocardial ischemia]. 150
[Infant mortality and sudden crib death in Lombardy]. 149
[Neonatal electrocardiography and the sudden infant death syndrome (SIDS)]. 148
A KCNH2 branch point mutation causing aberrant splicing contributes to an explanation of genotype-negative long QT syndrome. 148
Genetic testing in the long QT syndrome: development and validation of an efficient approach to genotyping in clinical practice 146
PREDESTINATION: PRimary vEntricular fibrillation and suDden dEath during a firST myocardIal iNfArcTION: Genetic basis. 144
Genotype-Phenotype correlation in the Long QT Syndrome. Gene-specific triggers for life-threatening arrhythmias 141
Identification of a KCNQ1 polymorphism acting as a protective modifier against arrhythmic risk in long-QT syndrome. 139
Spectrum and prevalence of mutations involving BrS1-12 susceptibility genes in a cohort of unrelated patients referred for Brugada Syndrome genetic testing: implications for genetic testing. 138
[Electrophysiologic features of the modulation of ATP-dependent potassium channels]. 137
[Idiopathic ventricular fibrillation: from a collection of clinical cases to a prospective evaluation. The U-CARE Steering Committee. Unexplained Cardiac Arrest Registry of Europe]. 137
FGF12 is a candidate Brugada syndrome locus. 134
Multiscale complexity analysis of the cardiac control identifies asymptomatic and symptomatic patients in long QT syndrome type 1. 134
25th anniversary of the International Long-QT Syndrome Registry: an ongoing quest to uncover the secrets of long-QT syndrome. 133
Aspetti elettrofisiologici della modulazione dei canali del potassio ATP-dipendenti 133
[Study of preganglionic sympathetic single fibers in relation to various physiologic and pathologic stimuli]. 131
Long QT syndrome-associated mutations in intrauterine fetal death. 131
A Molecular Link between the Sudden Infant Death Syndrome and the Long-QT Syndrome. 131
[Long QT syndrome and Brugada syndrome: 2 aspects of the same disease?]. 130
Antifibrillatory efficacy of ersentilide, a novel beta-adrenergic and Ikr blocker, in conscious dogs with a healed myocardial infarction. 129
Autonomic mechanisms and sudden death. New insights from analysis of baroreceptor reflexes in conscious dogs with and without a myocardial infarction. 128
Alpha 1-adrenergic blockade and sudden cardiac death. 127
Effect of Considering the Relatives' Quality of Life in Cost-Utility Studies 127
Linee Guida. Task Force sulla Morte Cardiaca Improvvisa, Società Europea di Cardiologia. Riassunto delle raccomandazioni 126
Sympathetic activation, ventricular repolarization and Ikr blockade: implications for the antifibrillatory efficacy of potassium channel blocking agents 125
Novel human pathological mutations. Gene symbol: SCN5A. Disease: Brugada Syndrome. 124
[Cardio-cardiac sympathico-vagal reflex]. 124
The genetics underlying acquired long QT syndrome: impact for genetic screening. 123
[Sympathetic reflex induced by experimental coronary occlusion]. 122
Cost-effectiveness of Neonatal ECG as a Screening for Long QT-syndrome: A Decision Analysis Approach. 121
Cardiac arrhythmias of genetic origin are important contributors to Sudden Infant Death Syndrome. 120
QT prolongation and sudden infant death syndrome - from theory to evidence. 120
[Evaluation of flecainide in the therapy of chronic ventricular arrhythmia using the acute oral load method]. 120
Electrocardiographic and genetic screening for long QT syndrome: results from a prospective study on 44,596 neonates. 119
Risk stratification in the Long-QT Syndrome 119
Role of common and rare variants in SCN10A: results from the Brugada syndrome QRS locus gene discovery collaborative study 119
A Recessive Variant of the Romano-Ward Long QT Syndrome 118
A novel rare variant in SCN1Bb linked to Brugada syndrome and SIDS by combined modulation of Na(v)1.5 and K(v)4.3 channel currents. 117
An experimental approach to the choice of antiarrhythmic therapy. 116
Cardiac potassium channel dysfunction in sudden infant death syndrome. 116
Adrenergic Arrhythmogenesis and The Long QT syndrome 116
Elucidating arrhythmogenic mechanisms of long-QT syndrome CALM1-F142L mutation in patient-specific induced pluripotent stem cell-derived cardiomyocytes 116
Age and sex-related differences in the clinical manifestations of congenital long QT syndrome: findings from the International Prospective LQTS Registry 116
All LQT3 patients need an ICD. True or false? 115
Inherited cardiac arrhythmia syndrome. Role of potassium channels 115
[Baroceptive reflex sensibility in non-anesthetized animals. Evaluation and comparison of 2 methods applicable to humans]. 115
Genetic Modifiers for the Long-QT Syndrome: How Important Is the Role of Variants in the 3′ Untranslated Region of KCNQ1? 115
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi002-A from a patient affected by the Jervell and Lange-Nielsen syndrome and carrier of two compound heterozygous mutations on the KCNQ1 gene 115
Cardiac sodium channel dysfunction in sudden infant death syndrome. 114
Arrhythmogenic disorders of genetic origin. Long QT Syndrome: from genetics to management. 114
A novel disease gene for Brugada syndrome: sarcolemmal membrane-associated protein gene mutations impair intracellular trafficking of hNav1.5. 114
[Neural mechanisms of sudden death]. 114
Farmaci antipsicotici, QT lungo, morte improvvisa e rischio cardiovascolare. Il cardiologo incontra lo psichiatra 114
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi007-A from a Long QT Syndrome type 1 patient carrier of two common variants in the NOS1AP gene 114
The LQT2 KCNH2-Q376Q splicing muation: functional characterization, molecular correction and therapeutic implication. 113
QT prolongation, sudden death, and sympathetic imbalance: the pendulum swings. 113
Autonomic nervous system and sudden cardiac death. Experimental basis and clinical observations for post-myocardial infarction risk stratification. 113
A common polymorphism associated with antibiotic-induced cardiac arrhythmia 113
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi005-A from a patient carrying the KCNQ1-R190W mutation 113
Unexplained cardiac arrest. The need for a prospective registry. 112
Autonomic nervous system, myocardial ischemia, and malignant ventricular arrhythmias: Experimental findings 112
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi003-A from a patient affected by an autosomal recessive form of Long QT Syndrome type 1 112
ALIVE Investigators: The efficacy of azimilide in the treatment of atrial fibrillation in the presence of left ventricular systolic dysfunction: results from the Azimilide Postinfarct Survival Evaluation (ALIVE) trial. 111
Mortalità infantile e morte improvvisa in culla in Lombardia 111
Baroreflex sensitivity predicts long-term cardiovascular mortality after myocardial infarction even in patients with preserved left ventricular function. 111
Autonomic Modulation for the Management of Patients with Chronic Heart Failure 111
Identification of a targeted and testable antiarrhythmic therapy for long-QT syndrome type 2 using a patient-specific cellular model 111
QT lungo, sindrome del 110
Rapid heart rate increase at onset of exercise predicts adverse cardiac events in patients with coronary artery disease 110
Ranolazine in the treatment of atrial fibrillation: Results of the dose-ranging RAFFAELLO (ranolazine in atrial fibrillation following an electrical cardioversion) study 110
[Sudden death after myocardial infarction. Prediction based on the baroreceptor reflex]. 109
KCNH2-K897T Is a Genetic Modifier of Latent Congenital Long-QT Syndrome. 107
[Long-QT caused by drugs and torsade de pointes: a genetic basis?]. 107
Prevalence of the congenital long-QT syndrome. 107
Autonomic nervous system and arrhythmias. 107
Baroreceptor reflexes and sudden cardiac death: experimental findings and background. 107
From patient-specific induced pluripotent stem cells to clinical translation in long QT syndrome Type 2 107
Individual autonomic profile contributes to the risk for life-threatening arrhythmias among KCNQ1-A341V mutation carriers 106
The long QT syndrome. Prospective longitudinal study of 328 families. 106
A molecular basis for the therapy of the long QT syndrome 106
Legal implications of medical guidelines. A task Force of the European Society of Cardiology 105
K+ channel blockade in the prevention of ventricular fibrillation in dogs with acute ischemia and enhanced sympathetic activity. 105
Atrial fibrillation requiring urgent medical care. Approach and outcome in the various departments of admission. Data from the atrial Fibrillation/flutter Italian REgistry (FIRE). 105
An International Multi-Center Evaluation of Type 5 Long QT Syndrome: A Low Penetrant Primary Arrhythmic Condition. 105
Spectrum of ST-T-wave patterns and repolarization parameters in congenital long-QT syndrome: ECG findings identify genotypes 104
The KCNH2-IVS9-28A/G mutation causes aberrant isoform expression and hERG trafficking defect in cardiomyocytes derived from patients affected by Long QT Syndrome type 2 104
Genotype-Phenotype Correlation in Induced Pluripotent Stem Cell (iPSC) Derived Cardiomyocytes Carrying Calmodulin Mutations 104
KCNH2-K897T is a genetic modifier of latent congenital long-QT syndrome. 104
The ICD for the long QT syndrome: which indications, complications, and results? 103
Totale 13.092
Categoria #
all - tutte 219.580
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 219.580


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.370 0 10 72 28 34 176 30 129 173 67 390 1.261
2022/20237.639 921 455 58 608 836 888 6 456 3.103 34 170 104
2023/20242.416 259 528 108 197 280 647 52 128 7 67 69 74
2024/20257.226 120 683 194 251 110 284 617 756 1.604 222 627 1.758
2025/202615.671 1.114 1.197 2.185 1.436 1.632 756 3.152 637 1.278 1.197 707 380
2026/20271.125 333 792 0 0 0 0 0 0 0 0 0 0
Totale 52.056